vimarsana.com
Home
Live Updates
Micron Biomedical Secures Series A Financing to Commercializ
Micron Biomedical Secures Series A Financing to Commercializ
Micron Biomedical Secures Series A Financing to Commercialize MAP Technology for Self-Administration of Drugs and Vaccines without Needles
/PRNewswire/ -- Micron Biomedical, Inc. is a clinical stage life sciences company advancing its Micro Array Patch (MAP) technology for self-administration and...
Related Keywords
China ,
Germany ,
Georgia ,
United States ,
Shanghai ,
Atlanta ,
Andernach ,
Rheinland Pfalz ,
Steven Damon ,
Mark Prausnitz ,
Centers For Disease ,
Venture Fund ,
Global Health Investment Fund ,
Biomedical Advanced Research ,
Melinda Gates Foundation ,
Development Authority ,
Global Health Investment Corporation ,
Micron Biomedical Inc ,
Prnewswire Micron Biomedical Inc ,
Georgia Research Alliance ,
Micro Array Patch ,
Disease Control ,
Georgia Research ,
Transdermal Patches ,
Oral Thin Films ,
Micro Array Patches ,
West Caldwell ,
Health Investment Fund ,
Micron Biomedical ,
Nc ,